Amazon is diving deeper into the healthcare business as it launches its new unlimited prescription medication service for just $5 per month. The e-commerce firm has named the service RxPass, and it is exclusively offered to Prime members.
Subscribers of Amazon Pharmacy’s RxPass will be able to enjoy free delivery of medicines even if they order many times. The healthcare subscription service was launched on Tuesday this week and is now available in most states in the U.S.
Moreover, Prime members can also save on medicines since special discounts are also applied on top of the free delivery to homes. This service only shows that the company is slowly but continuously expanding its footprint in the healthcare market.
As per Fox Business, the $5 flat monthly fee covers various medicines, including antibiotic amoxicillin, naproxen anti-inflammatory drug, and sildenafil which is typically used for the treatment of erectile dysfunction. This is commonly known as Viagra and is also said to have the ability to treat some types of high blood pressure.
Even with the low subscription fee for RxPass, customers can fill as many prescriptions as they need. As long as the medicines are on the list, and Amazon said it has 50 generic medications. Some of the generic drugs are said to cost only $1 for a 30-day supply already. For other discounts, they can get up to 80% off on generic and 40% off on brand-name medicines; thus, the subscription is beneficial.
“Prime members already get fast, free delivery on prescription medications, and RxPass is one more way to save with Amazon Pharmacy. Any customer who pays more than $10 a month for their eligible medications will see their prescription costs drop by 50% or more, plus they save time by skipping a trip to the pharmacy,” Amazon Pharmacy’s vice president, John Love, said in a press release. “We are excited to offer our customers surprisingly simple, low pricing on the eligible medications they need each month.”
Photo by: Bastian Riccardi/Pixabay


Wall Street Slides as U.S.-Iran Tensions Escalate; Tech Stocks Extend Losses in 2026
SpaceX IPO Demand Surges Past $250 Billion Ahead of Historic Market Debut
Asian Stocks Slide as Tech Selloff Deepens and US-Iran Conflict Escalates
SK Hynix Stock Rebounds as AI Memory Chip Demand Fuels Expansion Plans
Meta Partners With Reliance to Launch First AI-Powered Data Center in India
J.P. Morgan Sees Major Upside for Prysmian as Optical Fiber Prices Surge
South Korea Q1 GDP Growth Revised Higher as AI-Driven Exports Boost Economic Outlook
Oracle Stock Falls Despite Earnings Beat as Company Plans $40 Billion Financing for FY2027
New Zealand Unemployment and Inflation Debate Intensifies Ahead of 2026 Election
Wizz Air Beats Profit Forecast as Cost Controls Offset Industry Challenges
Trump Signals Opposition to USMCA Renewal as U.S. Reviews Trade Relations with Canada and Mexico
Wall Street Ends Mixed as Iran Tensions, OpenAI IPO Filing, and Inflation Concerns Weigh on Markets
US Dollar Edges Higher as Inflation Data and Middle East Tensions Shape Market Sentiment
US Stock Futures Rally as U.S.-Iran Peace Talks Boost Market Sentiment Despite Ongoing Strikes
Intesa Sanpaolo Launches €30.6 Billion Bid for Monte dei Paschi to Drive Italian Banking Consolidation
Asian Stocks Rebound as AI and Chip Shares Recover; Easing Iran Tensions Boost Sentiment 



